durvalumab - CAS 1428935-60-7
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C6502H10018N1742O2024S42
Molecular Weight:
146.3
COA:
Inquire
Targets:
PD-L1
Description:
Durvalumab is a human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody. It was approved by FDA for the treatment of patients with locally advanced or metastatic urothelial carcinoma who have disease progression during or following platinum-containing chemotherapy, or whose disease has progressed within 12 months of receiving platinum-containing chemotherapy before or after surgery.
Brife Description:
human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody
Synonyms:
Imfinzi
MSDS:
Inquire
Application:
the treatment of locally advanced or metastatic urothelial carcinoma
Current Developer:
AstraZeneca
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related PD-L1 Products


avelumab
(CAS: 1537032-82-8)

Avelumab is a human monoclonal antibody that is commonly used in immunotherapy and originally for non-small-cell lung carcinoma (NSCLC). It binds to the program...

PD-1/PD-L1 Inhibitor 1
(CAS: 1675201-83-8)

PD-1/PD-L1 Inhibitor 1, is an inhibitor of the PD-1 /PD-Ll protein/protein interaction.

durvalumab
(CAS: 1428935-60-7)

Durvalumab is a human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody. It was approved by FDA for the treatment of patients with locally advanced or metasta...

CA-170

A first-in-class oral, small molecule antagonist of PD-L1, PD-L2 and V-region immunoglobulin-containing suppressor of T cell activation (VISTA).

MSB-2311

MSB-2311 is a second-generation programmed cell death 1 ligand 1 (PD-L1) antibody with pH-dependent antigen binding property. The pH-dependent antigen binding p...

MPDL3280A
(CAS: 1380723-44-3)

A human, Fc optimized, monoclonal antibody directed against the protein ligand PD-L1 (programmed cell death-1 ligand 1), with potential immune checkpoint inhibi...

CAS 1673534-76-3 PD-1-IN-1

PD-1-IN-1
(CAS: 1673534-76-3)

PD-1-IN-1 is an inhibitor of programmed cell dealth-1 (PD-1).

MSB-0010718C

A human immunoglobulin G1 (IgG1) monoclonal antibody binds to PD-L1 and prevents the interaction of PD-L1 with its receptor PD-1, with potential immune checkpoi...

Quick Inquiry

Verification code

Featured Items